Vascular Medicine Consult Registry Launched for the SVS Vascular Quality Initiative
January 15, 2020—The Society for Vascular Surgery (SVS), the SVS Vascular Quality Initiative (VQI), and the American Heart Association (AHA) announced the introduction of the Vascular Medicine Consult (VMC) registry for the VQI—a collaboration of the SVS Patient Safety Organization (PSO), the Society for Vascular Medicine, and AHA.
Outcomes Published From Large Case Series of Complex AAA Treated With Terumo Aortic’s Fenestrated Anaconda Endograft
December 9, 2019—Findings from an assessment of the technical and clinical outcomes of the Fenestrated Anaconda endograft device (Terumo Aortic) in a large international case series were published online ahead of print in Journal of Vascular Surgery (JVS) by Arne de Niet, MD, et al, on behalf of the Fenestrated Anaconda Study Group.
CryoLife Receives CE Mark for E-nya Thoracic Stent Graft
December 2, 2019—CryoLife, Inc. announced it has received European CE Mark approval for the E-nya thoracic stent graft system for the minimally invasive repair of lesions of the descending thoracic aorta, including thoracic aortic aneurysms and dissections.
Medtronic Presents 1-Year Valiant Navion and 4-Year ANCHOR Registry Outcomes
November 22, 2019—Medtronic announced the presentation of 1-year outcomes for the Valiant Navion thoracic stent graft system for thoracic endovascular repair (TEVAR) and 4-year clinical outcomes from the ANCHOR registry evaluating the company’s Heli-FX EndoAnchor system in patients with hostile neck abdominal aortic aneurysms (AAAs) at the VEITHsymposium held November 19–23 in New York, New York.
Terumo Acquires Aortica Corporation to Further Bolster Its Vascular Graft Portfolio
November 20, 2019—Terumo Corporation announced the acquisition of Aortica Corporation, which developed the AortaFit automated case planning software to match fenestrations on an endograft with unique locations for each of a patient's branch arteries during fenestrated endovascular aneurysm repair (FEVAR) cases.
Endospan's Nexus Arch Branch Stent Graft System Studied at 2 Years
November 5, 2019—VIVA Physicians announced that 2-year results from a prospective, multicenter, premarket study composed of 25 patients (mean age, 73 years) treated with the Nexus aortic arch stent graft (Endospan) were presented by Daniel Clair, MD, in a late-breaking clinical trial session at VIVA 2019, the Vascular InterVentional Advances meeting held November 4–7 in Las Vegas, Nevada.
Medtronic's Valiant Navion TEVAR Device Approved and Launched in Japan
October 31, 2019—Medtronic announced the launch of the Valiant Navion thoracic stent graft in Japan, where the Ministry of Health, Labour and Welfare granted it Shonin approval for the endovascular repair of thoracic descending aortic aneurysms and complicated type B aortic dissections (TBADs).
Medtronic Gains FDA Breakthrough Device Designations for Valiant TAAA and Valiant Navion LSA Systems
October 8, 2019—Medtronic announced the receipt of FDA Breakthrough Device designations for the company’s Valiant thoracoabdominal aortic aneurysm (TAAA) stent graft system and the Valiant Navion left subclavian artery (LSA) branch thoracic stent graft system.
Sex-Specific Differences Evaluated in Management of Descending TAA
September 26, 2019—In European Journal of Vascular and Endovascular Surgery (2019;58:503–511), Pinar Ulug, MD, et al published findings from a systematic review with meta-analysis to evaluate sex-specific differences in the management of descending thoracic aortic aneurysms (TAAs).
Safety and Efficacy Data Published for Teleflex's Manta Closure Device
July 12, 2019—Findings from SAFE MANTA, the pivotal clinical study to evaluate the safety and effectiveness of the Manta percutaneous vascular closure device (Teleflex), were published by David A. Wood, MD, et al in Circulation: Cardiovascular Interventions.
Gore's TAG Conformable Thoracic Stent Graft With Active Control System Launched in the United States
July 10, 2019—Gore & Associates announced the commercial launch in the United States of the company's TAG conformable thoracic stent graft with Active Control system, with the first implantation of the device performed by William Jordan, MD, from Emory University School of Medicine in Atlanta, Georgia.
Low Rates of Neurologic Complications Seen in GREAT Registry of Gore's TEVAR Devices
June 26, 2019—In European Journal of Vascular and Endovascular Surgery (EJVES), Michele Piazza, MD, et al published findings from an evaluation of the incidence and predictors of early and midterm neurologic complications after thoracic endovascular aneurysm repair (TEVAR) in the GREAT registry.
Initial Experience Reported With Viabahn VBX as Bridging Stent Graft for Branched and Fenestrated EVAR
May 9, 2019—Online in Vascular and Endovascular Surgery, Sebastian Mafeld, MBBS, et al published findings from the initial experience with the balloon-expandable, heparin-bonded Viabahn VBX endoprosthesis (Gore & Associates) as a bridging stent graft (BSG) for branch and fenestrated endovascular aneurysm repair (FB-EVAR).
Sponsored by Medtronic
US Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.
European Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in Europe.
November 2019 Supplement